A critical appraisal of CSF monoamine metabolite studies in schizophrenia.
Widerlöv
E
E
Department of Psychiatry and Neurochemistry, University of Lund, Sweden.
D015102:3,4-Dihydroxyphenylacetic Acid / Q000134:cerebrospinal fluid; D015306:Biogenic Monoamines / Q000134:cerebrospinal fluid*; D004298:Dopamine / Q000134:cerebrospinal fluid; D006719:Homovanillic Acid / Q000134:cerebrospinal fluid; D006801:Humans; D006897:Hydroxyindoleacetic Acid / Q000134:cerebrospinal fluid; D008734:Methoxyhydroxyphenylglycol / Q000134:cerebrospinal fluid; D012559:Schizophrenia / Q000134:cerebrospinal fluid*
D015306:Biogenic Monoamines; D015102:3,4-Dihydroxyphenylacetic Acid; D008734:Methoxyhydroxyphenylglycol; D006897:Hydroxyindoleacetic Acid; D004298:Dopamine; D006719:Homovanillic Acid